Quotient Limited to Participate in the Jefferies Virtual Healthcare Conference
26 mai 2020 16h30 HE
|
Quotient Limited
JERSEY, Channel Islands, May 26, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the Company will present at the Jefferies...
Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call
26 mai 2020 08h00 HE
|
Quotient Limited
JERSEY, Channel Islands, May 26, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter...
Quotient Limited and hVIVO Announce Partnership to Support Wide-Spread COVID-19 Antibody Testing in the UK
11 mai 2020 02h00 HE
|
Quotient Limited
JERSEY, Channel Islands, May 11, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, and hVIVO, part of Open Orphan...
Quotient Limited Announces CE Mark for its SARS-CoV-2 (COVID-19) Antibody Microarray
01 mai 2020 09h00 HE
|
Quotient Limited
JERSEY, Channel Islands, May 01, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced...
Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Final Performance Data
27 avr. 2020 16h05 HE
|
Quotient Limited
JERSEY, Channel Islands, April 27, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported...
Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Performance Update
21 avr. 2020 16h05 HE
|
Quotient Limited
JERSEY, Channel Islands, April 21, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported...
Quotient Limited Announces the Completion of the SARS-CoV-2 Antibody Test Development
06 avr. 2020 08h00 HE
|
Quotient Limited
JERSEY, Channel Islands, April 06, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today...
Quotient Limited to Host Investor Information Conference Call and Live Webcast
13 mars 2020 16h30 HE
|
Quotient Limited
JERSEY, Channel Islands, March 13, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today...
Quotient Limited Reports Concordance Data from Extended Serological Disease Screening Benchmark Study
24 févr. 2020 16h05 HE
|
Quotient Limited
JERSEY, Channel Islands, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported...
Quotient Limited Announces CE Mark Approval for Initial Serological Disease Screening Microarray
14 févr. 2020 08h04 HE
|
Quotient Limited
JERSEY, Channel Islands, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced...